NCT06461910 2026-03-03
Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT06829355 2025-02-17
THYMI
Beijing Friendship Hospital
Phase 2 Recruiting
NCT06584006 2024-09-19
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
The First Affiliated Hospital of Xiamen University
Phase 2 Recruiting
NCT06598839 2024-09-19
Immuno-effect of Tα1 for Stage I NSCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT05086614 2021-10-21
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
Fudan University
Phase 3 Recruiting